Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-13
1996-10-22
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514293, 546 81, 546 83, 546 84, 546 88, A61K 3144, C07D47104, C07D491147
Patent
active
055677100
ABSTRACT:
In accordance with the present invention, there is provided a class of polycyclic fused ring compounds which are modulators of acetylcholine receptors. The compounds of the invention displace acetylcholine receptor ligands from their binding sites. Invention compounds may act as agonists, partial agonists, antagonists or allosteric modulators of acetylcholine receptors.
REFERENCES:
patent: 5399575 (1995-03-01), Friebe et al.
patent: 5418229 (1995-05-01), Alker et al.
Glassco W, Suchocki J, George C, Martin B R & May E L. (1993) J. Med. Chem. 36, 3381-3385.
Albanese et al., "Chronic Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine to Monkeys: Behavioural, Morphological and Biochemical Correlates" Neuroscience 55:823-832 (1993).
Brandsma et al., "3-Deuterio- and (3-Methylthio)Pyridine" Preparative Polar Organometallic Chemistry 1:172-173 (1987).
Brioni et al., "Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test" Eur. J. Pharmacol. 238:1-8 (1993).
Chorvat et al., "Total Synthesis of 2-Azaestratrienes" J. Org. Chem. 43(5):966-972 (1978).
Christensen et al., "On the Supersensitivity of Dopamine Receptors, Induced by Neuroleptics" Psychoparmacol. 48:1-6 (1976).
Clow et al., "Changes in Dopamine-Mediated Behaviour During One Year's Neuroleptic Administration" Euro. J. Pharmacol. 57:365-375 (1979).
Colpaert, F. C., "Pharmacological Characteristics of Tremor, Rigidity and Hypokinesia Induced by Reserpine in Rat" Neuropharmacol. 26(9):1431-1440 (1987).
Cordonnier and Sliwa, "Synthesis of New Funcatmental Heterocycles, Part VIII. A New Syntheiss of 2H-Pyrano[3,2-c] pyridine" J. Chem. Research vol. 124 (1979).
Coyle et al., "Kainic Acid: Insights from a Neurotoxin into the Pathophysiology of Huntington's Disease" Neurobehav. Toxicol. Tetatol. 5:617-624 (1983).
D'Amour and Smith, "A Method for Determining Loss of Pain Sensation" J. Pharmacol. Exp. Ther. 72:74-79 (1941).
Emerich et al., "Nicotine Potentiates Haloperidol-Induced Catalepsy and Locomotor Hypoactivity" Pharmacol. Biochem. Behav. 38:875-880 (1991).
Estrella et al., "A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity" Br. J. Pharmacol. 93:759-768 (1988).
Flynn and Mash, "Characterization of L-[.sup.3 H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal" J. Neurochemistry 47(6):1948-1954 (1986).
Garcia and Greco, "Facile Bromination of Pyridine-Type Heterocycles at the .beta.-Position" J. Am. Chem. Soc. 82:4430-4431 (1960).
Iwamoto, Edgar T., "Antinociception after Nicotine Administration into the Mesopontine Tegmentum of Rats: Evidence for Muscarinic Actions" J. Pharmacol. Exp. Ther. 251(21):412-421 (1989).
Janson et al., "Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse" Clin. Investig. 70:232-238 (1992).
Klockgether and Turski, "NMDA Antagonists Potentiate Antiparkinsonian Actions of .sub.L -Dopa in Monoamine-depleted Rats" Ann. Neurol. 28:539-546 (1990).
Miyata et al., "Role of the Serotonin.sub.3 Receptor in Stress-Induced Defecation" J. Pharmacol. Exp. Ther. 261(1):297-303 (1992).
Pellow et al., "Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat" Neurosci. Meth. 14:149-167 (1985).
Ranganathan et al., "Nitroethylene: A Stable, Clean, and Reactive Agent for Organic Synthesis" J. Org. Chem. 45:1185-1189 (1980).
Rupniak et al., "Cholinergic Manipulation of Perioral Behaviour Induced by Chronic Neuroleptic Administration to Rats" Psychopharmacol. 79:226-230 (1983).
Sacaan et al., "Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That is Mediated by Striatal Dopamine" J. Neurochem. 59(1):245 (1992).
Scharcz et al., "Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain" Science 219:316-318 (1983).
Sershen et al., "Behavioral and Biochemical Effects of Nicotine in an MPTP-Induced Mouse Model of Parkinson's Disease" Pharmacol. Biochem. Behav. 28:299-303 (1987).
Sundstrom et al., "Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease" Brain Res. 528:181-188 (1990).
Ungerstedt et al., "Animal Models of Parkinsonism" Adv. Neurol. 3:257-271 (1973).
Ungerstedt and Arbuthnott, "Quantitative Recording of Rotational Behavior in Rats After 6-Hydroxy-Dopamine Lesions of the Nigrostriatal Dopamine System" Brain Research 24:485-493 (1970).
Von Voightlander and Moore, "Turning Behavior of Mice with Unilateral 6-Hydroxydopamine Lesions in the Striatum: Effects of Apomorphine, .sub.L -Dopa, Amantadine, Amphetamine and Other Psychomotor Stimulants" Neuropharmacology 12:451-462 (1973).
Waddington et al., "Spontaneous Orofacial Dyskinesia and Dopaminergic Function in Rats After 6 Months of Neuropeptic Treatment" Science 220:530-532 (1983).
Williams et al., "Stress-Induced Changes in Intestinal Transit in the Rat: A Model for Irritable Bowel Syndrome" Gastroenterology 94:611-621 (1988).
Williams et al., "Neuronal Nicotinic Acetylcholine Receptors" Drug News & Perspectives 7(4):205-223 (1994).
Yamada et al., "Effects of a thienylalkylamine derivative, T-1815, on colonic propulsion in mice and rats" Jpn. J. Pharmacol. 58 (Suppl.):131 (1992).
Alkondon and Albuquerque, "Diversity of Nicotinic Acetylcholine Receptors in Rat Hippocampal Neurons. III. Agonist Actions of the Novel Alkaloid Epibatidine and Analysis of Type II Current" J. Pharmacol. Exper. Therap. 274:771-782 (1995).
Anderson et al., "Characterization of [.sup.3 H]ABT-418: A Novel Cholinergic Channel Ligand" J. Pharmacol. Exper. Therap. 273:1434-1441 (1995).
Chaki et al., "Design and Syntheses of 4-Acylaminopyridine Derivatives: Novel High Affinity Choline Uptake Enhancers I.sup.1 " Bioorgan. & Med. Chem. Let. 5:1489-1494 (1995).
De Fiebre et al., "Characterization of a Series of Anabaseine-Derived Compounds Reveals That the 3-(4)-Dimethylaminocinnamylidine Derivative Is a Selective Agonist at Neuronal Nicotinic .alpha.7/.sup.125 .vertline.-.alpha.-Bungarotoxin Receptor Subtypes" Mol. Pharmacol. 47:164-171 (1995).
Hansson et al., "On the Quantitative Structure--Activity Relationships of Meta-Substituted (S)-Phenylpiperidines, a Class of Preferential Dopamine D.sub.2 Autoreceptor Ligands: Modeling of Dopamine Synthesis and Release in Vivo by Means of Partial Least Squares Regression" J. Med. Chem. 38:3121-3131 (1995).
Kashiwabara et al., "Comparative Vasodepressor Effects of 3-Pyridine Derivatives Possessing the Cyanoamidine or Amide Structure in Pithed Rats" Arch. int. Pharmacodyn 328:297-306 (1994).
Natsugari et al., "Novel, Potent, and Orally Active Substance P Antagonists: Synthesis and Antagonist Activity of N-Benzylcarboxamide Derivatives of Pyrido[3,4-b]pyridine" 38:3106-3120 (1995).
Glassco et al., "Synthesis, Optical Resolution, Absolute Configuration, and Preliminary Pharmacology of (+)-and (-)-cis-2,3,3a,4,5,9b-Hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoquinoline, a Structural Analog of Nicotine" J. Med. Chem. 36:3381-3385 (1993).
McDonald Ian A.
Vernier Jean-Michel
Whitten Jeffrey P.
Huang Evelyn
Ivy C. Warren
Reiter Stephen E.
SIBIA Neurosciences Inc.
LandOfFree
Polycyclic fused ring modulators of acetylcholine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polycyclic fused ring modulators of acetylcholine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic fused ring modulators of acetylcholine receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358857